Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Women Diagnosed With Cancer 1Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Vitrification × Clear all
NCT03680937 2018-09-21

OVOMIV

University Hospital, Clermont-Ferrand

Unknown
240 enrolled
Tumor-Agnostic

Neoplasms

NCT01223105 2013-11-19

Oocyte Cryopreservation by Slow Freezing and Vitrification

Reproductive Medicine Associates of New Jersey

Phase 2/3 Terminated
2 enrolled

Women Diagnosed With Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡